Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.
Kush V. Bhatt, Joseph Friedman, Lindsay L Benster, Rekha Narasimhan, Kevin H. Yang, Jyoti Mishra, Cory R. Weissman, Dhakshin Ramanathan
Community Mental Health Journal April 1, 2026 DOI: 10.1007/s10597-026-01620-x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Retrospective chart review Peer reviewed |
|---|---|
| Sample size | 232 |
| Population | Emergency department patients with recreational psychedelic use |
| Keywords | Psychedelic Emergency department Hallucinogen Substance use |
| Key findings | Concurrent cannabis use, history of bipolar disorder, and history of a primary psychotic disorder were associated with increased odds of psychiatric hospitalization among patients with psychedelic-associated emergency visits. |
Abstract
Recreational psychedelic use is increasing, yet data on adverse events remains limited. This study characterized emergency department (ED) visits associated with recreational psychedelic use at UC San Diego Medical Center. We conducted a retrospective chart review of ED encounters (2010–2023). Cases were identified using ICD-10 hallucinogen-related codes and confirmed through manual review. Multivariable logistic regression was employed to identify factors associated with psychiatric hospitalization. We identified 232 cases, primarily related to LSD (35.0%), MDMA (30.2%), and psilocybin (24.0%). The cohort was predominantly young, white, and male. Common psychiatric symptoms included agitation (25.9%) and anxiety (24.6%). Common nonpsychiatric symptoms included nausea/vomiting (9.5%) and diaphoresis (5.2%). 11.2% of cases required psychiatric hospitalization. Factors associated with psychiatric hospitalization included concurrent cannabis use (OR = 10.9, 95% CI 3.37–39.64), history of bipolar disorder (OR = 12.67, 95% CI 2.35–70.43), and history of a primary psychotic disorder (OR = 17.10, 95% CI 2.01–187.49). Psychedelic-associated emergency visits present with various clinical characteristics. While most recreational psychedelic presentations are effectively managed in the emergency department, specific factors predict severe outcomes. Concurrent cannabis use and pre-existing psychotic or bipolar disorders are associated with increased odds of psychiatric hospitalization, underscoring the importance of targeted risk assessment in patients with these vulnerabilities.
Citations in the library
Cites 35
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine November 3, 2022
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Single-Dose Psilocybin Treatment for Major Depressive Disorder JAMA August 31, 2023
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology February 2, 2022
and 30 more in the library